BISMUTH MARKET ANALYSIS

Market News

Recent Developments:

• In March 2023, Endo International plc. announced that one of its operating companies, Par Pharmaceutical, Inc., began shipping the first generic version of Allergan's Pylera (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) 140 mg, 125 mg, and 125 mg capsules in the U.S., following final approval from the U.S. Food and Drug Administration (FDA) of its abbreviated new drug application. Endo International plc. is a specialty pharmaceutical company. The company is committed to improve the lives of patients through the development, manufacturing, marketing, and distribution of high-value branded pharmaceutical products, generic pharmaceuticals, and sterile injectable.
• In March 2022, OFS and Viavi Solutions announced their collaboration on a test and measurement-focused amplifier based on a new OFS Bismuth-doped fiber which could be produced at sufficient volumes to meet the growing demand for 400GbE and 800GbE test applications worldwide. OFS is a U.S.-based technology company known for designing and manufacturing fiber optic solutions. Viavi Solutions is an U.S.-based network test, measurement, and assurance technology company. Viavi Solutions manufactures testing and monitoring equipment for networks and develops optical technology for various applications including material quality control, currency anti-counterfeiting, and 3D motion sensing.